Literature DB >> 22411060

Early lung cancer detection using the self-evaluation scoring questionnaire and chest digital radiography: a 3-year follow-up study in China.

Bojiang Chen1, Youjuan Wang, Huibi Cao, Dan Liu, Shangfu Zhang, Jun Gao, Jianqun Yu, Yan Huang, Weimin Li.   

Abstract

The standard definition of high-risk individuals for lung cancer was not uniform and the value of chest digital radiography (DR) in lung cancer screening was still unproven. The aim of this study was to assess whether the original questionnaire named as "Self-evaluation Scoring Questionnaire for High-risk Individuals of Lung Cancer" combined with DR examinations could detect early stage of lung cancer effectively. The Self-evaluation Scoring Questionnaire for High-risk Individuals of Lung Cancer had been designed in previous studies. Subjects with scores over 116 points were regarded as high-risk individuals and underwent the current DR scans at least once a year from 2007 to 2009. Noncalcified nodules with a diameter over 30 mm, along with enlarged pulmonary hilus and atelectasis, were considered to be positive and subjected to further special examinations. Efficacy of the scoring questionnaire combined with DR scans was estimated by 3-year results. Among 1,537 subjects, 13, 11, and 7 were diagnosed with lung cancer in the first, second, and third year, respectively, indicating the detection rate of 2.02 % (31/1,537). In addition, 77.42 % (24/31) of the patients were in stage I and 51.61 % (16/31) were adenocarcinomas. For the 31 cases, 28 were defined as detected cancers, while the other three were interval ones, only accounting for 0.20 % (3/1,504) of individuals with negative judgments. The protocol of Self-evaluation Scoring Questionnaire for High-risk Individuals of Lung Cancer combined with DR scans is a cost-effective and safe approach to detect early stage of lung cancer.

Entities:  

Mesh:

Year:  2013        PMID: 22411060      PMCID: PMC3553372          DOI: 10.1007/s10278-012-9468-4

Source DB:  PubMed          Journal:  J Digit Imaging        ISSN: 0897-1889            Impact factor:   4.056


  28 in total

1.  Does lung cancer screening with chest X-ray improve disease-free survival?

Authors:  Ian Hunt; Mayooran Siva; Rachel Southon; Tom Treasure
Journal:  Interact Cardiovasc Thorac Surg       Date:  2006-04-19

Review 2.  Solitary pulmonary nodules: detection, characterization, and guidance for further diagnostic workup and treatment.

Authors:  Yeong Joo Jeong; Chin A Yi; Kyung Soo Lee
Journal:  AJR Am J Roentgenol       Date:  2007-01       Impact factor: 3.959

3.  Role of baseline nodule density and changes in density and nodule features in the discrimination between benign and malignant solid indeterminate pulmonary nodules.

Authors:  Dong Ming Xu; Rob J van Klaveren; Geertruida H de Bock; Anne L M Leusveld; Monique D Dorrius; Yingru Zhao; Ying Wang; Harry J de Koning; Ernst T Scholten; Johny Verschakelen; Mathias Prokop; Matthijs Oudkerk
Journal:  Eur J Radiol       Date:  2008-04-15       Impact factor: 3.528

4.  Three-year findings of an early lung cancer detection feasibility study with low-dose spiral computed tomography in heavy smokers.

Authors:  S Novello; C Fava; P Borasio; L Dogliotti; G Cortese; B Crida; G Selvaggi; P Lausi; M P Brizzi; P Sperone; L Cardinale; F Ferraris; F Perotto; A Priola; G V Scagliotti
Journal:  Ann Oncol       Date:  2005-07-08       Impact factor: 32.976

5.  Evaluation of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition).

Authors:  Michael K Gould; James Fletcher; Mark D Iannettoni; William R Lynch; David E Midthun; David P Naidich; David E Ost
Journal:  Chest       Date:  2007-09       Impact factor: 9.410

Review 6.  Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).

Authors:  Anthony J Alberg; Jean G Ford; Jonathan M Samet
Journal:  Chest       Date:  2007-09       Impact factor: 9.410

7.  Cancer statistics, 2008.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Taylor Murray; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2008-02-20       Impact factor: 508.702

8.  Lung cancer screening.

Authors:  Peter B Bach
Journal:  J Natl Compr Canc Netw       Date:  2008-03       Impact factor: 11.908

9.  Lung cancer screening with low-dose computed tomography: Canadian experience.

Authors:  Heidi C Roberts; Demetris Patsios; Narinder S Paul; Maureen McGregor; Gordon Weisbrod; Taebong Chung; Steven Herman; Scott Boerner; Thomas Waddell; Shafique Keshavjee; Gail Darling; Andre Pereira; Ashwini Kale; Hamid Bayanati; Igor Sitartchouk; Ming Tsao; Frances A Shepherd
Journal:  Can Assoc Radiol J       Date:  2007-10       Impact factor: 2.248

10.  Lung cancer screening with spiral CT: baseline results of the randomized DANTE trial.

Authors:  Maurizio Infante; Fabio Romano Lutman; Silvio Cavuto; Giorgio Brambilla; Giuseppe Chiesa; Eliseo Passera; Enzo Angeli; Maurizio Chiarenza; Giuseppe Aranzulla; Umberto Cariboni; Marco Alloisio; Matteo Incarbone; Alberto Testori; Anna Destro; Federico Cappuzzo; Massimo Roncalli; Armando Santoro; Gianluigi Ravasi
Journal:  Lung Cancer       Date:  2007-10-23       Impact factor: 5.705

View more
  2 in total

1.  Clinical effectiveness and clinical toxicity associated with platinum-based doublets in the first-line setting for advanced non-squamous non-small cell lung cancer in Chinese patients: a retrospective cohort study.

Authors:  Yan Wang; Jianhua Chen; Shengqi Wu; Chenping Hu; Xiaoling Li; Yuqin Wang; Yicheng Yang; Narayan Rajan; Yun Chen; Yi Chen; Zhuanzhuan Luo; Wendong Chen
Journal:  BMC Cancer       Date:  2014-12-12       Impact factor: 4.430

2.  Real-world hospital costs for nonchemotherapy drugs and nondrug care associated with platinum-based doublets in the first-line setting for advanced nonsquamous non-small-cell lung cancer in Chinese patients: a retrospective cohort study.

Authors:  Jianhua Chen; Shengqi Wu; Chenping Hu; Yicheng Yang; Narayan Rajan; Yun Chen; Canjuan Yang; Jianfeng Li; Wendong Chen
Journal:  Clinicoecon Outcomes Res       Date:  2016-04-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.